Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467343) titled 'Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ain Shams University
Condition:
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms
Intervention:
Drug: Silodosin
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: March 22, 2026
Target Sample Size: 140
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07467343
Disclai...